an organization dedicated to improving the lives of Canadians above the age of 45, will help to disseminate accurate information and quality products to a patient demographic that is highly engaged in learning more about how medical cannabis can improve their quality of life when conventional medicine just isn’t enough.”
We still need the old to tell the young that in time, they will learn.
— Giovannie de Sadeleer
"
"
The bottom line is, there is plenty of opportunity out there for publicly traded companies in the cannabis space. There is considerable research and product offerings are expanding to recognize the need for alternative delivery methods for the aging population such as seniors, but that does not preclude other younger age brackets or demographics from utilizing these methods. Methods that I would suggest will be far more popular in the not-so-distant-future than good old-fashioned smoking, or even vaping! A reverse cohort effect perhaps? Ultimately, the more research that is done on the therapeutic effects of cannabis for elderly patients, the greater the probability that more and more seniors will at least try. Given that powerful opioids are among the other available options currently, there isn’t much to lose. A lot to gain, for both the elderly medical cannabis user, AND those companies that have recognized this demographic.
The article is for discussion and illustrative purposes only and not an investment recommendation or signal for any company, sector, or industry. Investors are solely responsible for their own investment decisions. The article is not a paid endorsement. No financial compensation was received from any company mentioned in this article. The information and materials are provided as a general source of information. While every measure has been taken to ensure the accuracy of the material, we do not guarantee the accuracy or completeness of the material. It is not intended as investment, financial, legal, accounting, tax or other advice. The dynamics are changing frequently. Any information or materials which are provided or maintained by a third party such as linked sites and references which may be accessed but are provided “as is”. We will not be responsible in any manner for direct, indirect or special damages, howsoever caused, arising out of the use of this information.
252